These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 28802541

  • 1. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [Abstract] [Full Text] [Related]

  • 2. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.
    Muslu CS, Kopetsky M, Nimmer M, Visotcky A, Fraser R, Brousseau DC.
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28268. PubMed ID: 32614150
    [Abstract] [Full Text] [Related]

  • 3. Opioid prescription practices at discharge and 30-day returns in children with sickle cell disease and pain.
    Okorji LM, Muntz DS, Liem RI.
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27800652
    [Abstract] [Full Text] [Related]

  • 4. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD, McCavit TL.
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
    Wilson TT, Chou SC, Becker S, Schuur JD, Beaudoin F.
    Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
    [Abstract] [Full Text] [Related]

  • 6. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.
    Glassberg J, Simon J, Patel N, Jeong JM, McNamee JJ, Yu G.
    Am J Emerg Med; 2015 Oct; 33(10):1396-401. PubMed ID: 26283616
    [Abstract] [Full Text] [Related]

  • 7. The Effect of Use of Individualized Pain Plans in Sickle Cell Patients Presenting to the Emergency Department.
    Della-Moretta S, Delatore L, Purcell M, Huang Y, Heinlein M, Adkins E, Desai P.
    Ann Emerg Med; 2020 Sep; 76(3S):S21-S27. PubMed ID: 32928458
    [Abstract] [Full Text] [Related]

  • 8. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P, Martinovich Z, Buckley B, Schmelzer A, Paice JA.
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [Abstract] [Full Text] [Related]

  • 9. Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease.
    Brandow AM, Nimmer M, Simmons T, Charles Casper T, Cook LJ, Chumpitazi CE, Paul Scott J, Panepinto JA, Brousseau DC.
    Am J Hematol; 2016 Dec; 91(12):1175-1180. PubMed ID: 27517842
    [Abstract] [Full Text] [Related]

  • 10. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P, Artz N, Mark Courtney D, Martinovich Z, Weiss KB, Zvirbulis E, Hafner JW.
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [Abstract] [Full Text] [Related]

  • 11. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J, Aban I, Hilliard LM, Madison J, Bemrich-Stolz C, Howard TH, Brandow A, Waite E, Lebensburger JD.
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
    [Abstract] [Full Text] [Related]

  • 12. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR.
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [Abstract] [Full Text] [Related]

  • 13. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P, Hafner JW, Martinovich Z, Artz N.
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [Abstract] [Full Text] [Related]

  • 14. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A, Ward R, Phua C, Naessens V, O'Brien T, Bhatia S, Baranek H, Marani H, Mukerji G.
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [Abstract] [Full Text] [Related]

  • 15. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
    Givens M, Rutherford C, Joshi G, Delaney K.
    J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
    [Abstract] [Full Text] [Related]

  • 16. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R, Blakemore S, Waite E, Pernell B, Madan-Swain A, Hilliard L, Lebensburger J.
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P, Silva S, Bosworth HB, Crawford R, Paice JA, Richardson LD, Miller CN, Glassberg J.
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [Abstract] [Full Text] [Related]

  • 18. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.
    Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F.
    J Emerg Med; 2015 Oct; 49(4):513-522.e1. PubMed ID: 25910824
    [Abstract] [Full Text] [Related]

  • 19. A Standardized Emergency Department Order Set Decreases Admission Rates and In-Patient Length of Stay for Adults Patients with Sickle Cell Disease.
    Wachnik AA, Welch-Coltrane JL, Adams MCB, Blumstein HA, Pariyadath M, Robinson SG, Saha A, Summers EC, Hurley RW.
    Pain Med; 2022 Dec 01; 23(12):2050-2060. PubMed ID: 35708651
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
    Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R.
    Ann Intern Med; 2021 Sep 01; 174(9):1207-1213. PubMed ID: 34224261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.